An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation

Journal of Clinical Investigation

Volumn 117, Issue 2, 2007, Pages 353-363

  High, Frances A ^a   Zhang, Maozhen ^a,c   Proweller, Aaron ^a   Tu, LiLi ^a,b   Parmacek, Michael S ^a   Pear, Warren S ^a,b   Epstein, Jonathan A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; AORTA ARCH ANOMALY; ARTICLE; CARDIOVASCULAR MALFORMATION; CONTROLLED STUDY; HEART DEVELOPMENT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE DEVELOPMENT; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY STENOSIS; SMOOTH MUSCLE;

ANIMALS; CARDIOVASCULAR ABNORMALITIES; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; GENOTYPE; HUMANS; MICE; MICE, MUTANT STRAINS; MUSCLE, SMOOTH; NEURAL CREST; PHENOTYPE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 33846839628     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30070     Document Type: Article

References (50)

1. Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. 1999. Notch signaling: cell fate control and signal integration in development. Science. 284:770-776.
2. Fischer, A., and Gessler, M. 2003. Hey genes in cardiovascular development. Trends Cardiovasc. Med. 13:221-226.
3. Iso, T., Kedes, L., and Hamamori, Y. 2003. HES and HERP families: multiple effectors of the notch signaling pathway. J. Cell. Physiol. 194:237-255.
4. Oda, T., et al. 1997. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 16:235-242.
5. Li, L., et al. 1997. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16:243-251.
6. McElhinney, D.B., et al. 2002. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation. 106:2567-2574.
7. Garg, V., et al. 2005. Mutations in NOTCH1 cause aortic valve disease. Nature. 437:270-274.
8. McCright, B., Lozier, J., and Gridley, T. 2002. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development. 129:1075-1082.
9. Gessler, M., et al. 2002. Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr. Biol. 12:1601-1604.
10. Donovan, J., Kordylewska, A., Jan, Y.N., and Utset, M.F. 2002. Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice. Curr. Biol. 12:1605-1610.
11. Sakata, Y., et al. 2002. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc. Natl. Acad. Sci. U. S. A. 99:16197-16202.
12. Kirby, M.L., Gale, T.F., and Stewart, D.E. 1983. Neural crest cells contribute to normal aorticopulmonary septation. Science. 220:1059-1061.
13. Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., and Sucov, H.M. 2000. Fate of the mammalian cardiac neural crest. Development. 127:1607-1616.
14. Stoller, J.Z., and Epstein, J.A. 2005. Cardiac neural crest. Semin. Cell Dev. Biol. 16:704-715.
15. Morrow, D., et al. 2005. Notch-mediated CBF-1/RBP-Jκ-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am. J. Physiol. Cell Physiol. 289:C1188-C1196.
16. Wang, W., Prince, C.Z., Hu, X., and Pollman, M.J. 2003. HRT1 modulates vascular smooth muscle cell proliferation and apoptosis. Biochem. Biophys. Res. Commun. 308:596-601.
17. Sakata, Y., et al. 2004. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arterioscler. Thromb. Vasc. Biol. 24:2069-2074.
18. Sweeney, C., et al. 2004. Notch 1 and 3 receptors modulate vascular smooth muscle cell growth, apoptosis and migration via a CBF-1/RBP-Jk dependent pathway. FASEB J. 18:1421-1423.
19. Doi, H., et al. 2006. Jagged1-selective Notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway. J. Biol. Chem. 281:28555-28564.
20. Doi, H., et al. 2005. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler. Thromb. Vasc. Biol. 25:2328-2334.
21. Proweller, A., Pear, W.S., and Parmacek, M.S. 2005. Notch signaling represses myocardin-induced smooth muscle cell differentiation. J. Biol. Chem. 280:8994-9004.
22. Noseda, M., et al. 2006. Smooth muscle α-actin is a direct target of Notch/CSL. Circ. Res. 98:1468-1470.
23. Shutter, J.R., et al. 2000. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 14:1313-1318.
24. Wu, L., and Griffin, J.D. 2004. Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis. Semin. Cancer Biol. 14:348-356.
25. Nam, Y., Sliz, P., Song, L., Aster, J.C., and Blacklow, S.C. 2006. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcriptional complexes. Cell. 124:973-983.
26. Maillard, I., et al. 2004. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood. 104:1696-1702.
27. Tu, L., et al. 2005. Notch signaling is an important regulator of type 2 immunity. J. Exp. Med. 202:1037-1042.
28. Engleka, K.A., et al. 2005. Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives. Dev. Biol. 280:396-406.
29. Weinmaster, G., and Kintner, C. 2003. Modulation of notch signaling during somitogenesis. Annu. Rev. Cell Dev. Biol. 19:367-395.
30. Luo, D., Renault, V.M., and Rando, T.A. 2005. The regulation of Notch signaling in muscle stem cell activation and postnatal myogenesis. Semin. Cell Dev. Biol. 16:612-622.
31. Mao, X., Fujiwara, Y., Chapdelaine, A., Yang, H., and Orkin, S.H. 2001. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood. 97:324-326.
32. Novak, A., Guo, C., Yang, W., Nagy, A., and Lobe, C.G. 2000. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis. 28:147-155.
33. Brown, C.B., et al. 2001. PlexinA2 and semaphorin signaling during cardiac neural crest development. Development. 128:3071-3080.
34. Shen, H., et al. 2006. The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev. 20:675-688.
35. Anderson, J.P., et al. 2004. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol. Cell. Biol. 24:3757-3768.
36. Zhang, J.C., et al. 2001. Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol. Cell. Biol. 21:1336-1344.
37. Lepore, J.J., et al. 2005. High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22α-Cre transgenic mice. Genesis. 41:179-184.
38. Cornell, R.A., and Eisen, J.S. 2005. Notch in the pathway: the roles of Notch signaling in neural crest development. Semin. Cell Dev. Biol. 16:663-672.
39. Morrison, S.J., et al. 2000. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell. 101:499-510.
40. Joseph, N.M., et al. 2004. Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells. Development. 131:5599-5612.
41. Joutel, A., et al. 1996. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 383:707-710.
42. Domenga, V., et al. 2004. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 18:2730-2735.
43. Kamath, B.M., et al. 2004. Vascular anomalies in Alagille syndrome, a significant cause of morbidity and mortality. Circulation. 109:1354-1358.
44. Kaartinen, V., et al. 2004. Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells. Development. 131:3481-3490.
45. Wurdak, H., et al. 2005. Inactivation of TGFβ signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev. 19:530-535.
46. Choudhary, B., et al. 2005. Cardiovascular malformations with normal smooth muscle differentiation in neural crest-specific type II TGFβ receptor (Tgfbr2) mutant mice. Dev. Biol. 289:420-429.
47. Li, J., et al. 2005. Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc. Natl. Acad. Sci. U. S. A. 102:8916-8921.
48. Oh, J., Richardson, J.A., and Olson, E.N. 2005. Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc. Natl. Acad. Sci. U. S. A. 102:15122-15127.
49. Wawersik, S., and Epstein, J.A. 2000. Gene expression analysis by in situ hybridization. Radioactive probes. Methods Mol. Biol. 137:87-96.
50. Lepore, J.J., Cappola, T.P., Mericko, P.A., Morrisey, E.E., and Parmacek, M.S. 2005. GATA-6 regulates genes promoting synthetic functions in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25:309-314.